Zobrazeno 1 - 10
of 154
pro vyhledávání: '"Paul W. Stewart"'
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-20 (2023)
Abstract Background Child maltreatment (CM) is a pervasive public health problem and there is a critical need for brief, effective, scalable prevention programs. Problematic parent-child relationships lie at the heart of CM. Parents who maltreat thei
Externí odkaz:
https://doaj.org/article/326cd6ef846d4cfeb3d5b49123614758
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 22, Iss 1 (2019)
PURPOSE: Probe substrates are used routinely to assess transporter function in vitro. Administration of multiple probe substrates together as a “cocktail” in sandwich-cultured human hepatocytes (SCHH) could increase the throughput of transporter
Externí odkaz:
https://doaj.org/article/31f9c402e451431fadac44c8e9b51e28
Autor:
Bryce B. Reeve, Larry Michael, Joy A. Peter, Paul W. Stewart, Anna S.-F. Lok, Meichen Dong, Ken Bergquist, David R. Nelson, Donna M. Evon
Publikováno v:
GastroHep. 2022:1-9
Background. Despite high efficacy rates for direct acting antiviral regimens to cure hepatitis C virus infection, many patients experience treatment-related symptoms. Accurate reporting of adverse events is mandatory to determine drug safety. Previou
Autor:
Donna M, Evon, Meichen, Dong, Bryce B, Reeve, Joy, Peter, Larry, Michael, Anna S, Lok, David R, Nelson, Paul W, Stewart
Publikováno v:
Journal of Viral Hepatitis. 29:795-806
The PRIORITIZE trial (clinicaltrials.gov: NCT02786537) was the first comparative effectiveness study to directly compare ledipasvir/sofosbuvir (LDV/SOF) and elbasvir/grazoprevir (EBR/GZR) for the treatment of chronic hepatitis C virus (HCV). A second
Autor:
Donna M Evon, Paul W Stewart, Jipcy Amador, Marina Serper, Anna S Lok, Richard K Sterling, Souvik Sarkar, Carol E Golin, Bryce B Reeve, David R Nelson, Nancy Reau, Joseph K Lim, K Rajender Reddy, Adrian M Di Bisceglie, Michael W Fried
Publikováno v:
PLoS ONE, Vol 13, Iss 8, p e0196908 (2018)
BACKGROUND:Symptom burden, medical comorbidities, and functional well-being of patients with chronic hepatitis C virus (HCV) initiating direct acting antiviral (DAA) therapy in real-world clinical settings are not known. We characterized these patien
Externí odkaz:
https://doaj.org/article/7e51805751e8433faa26e2146543c158
Autor:
Jipcy Amador, David R. Nelson, Marina Serper, Richard K. Sterling, Michael W. Fried, Joseph K. Lim, K. Rajender Reddy, Paul W. Stewart, Carol E. Golin, Souvik Sarkar, Nancy Reau, Donna M. Evon, Anna S. Lok, Bryce B. Reeve, Adrian M. Di Bisceglie
Publikováno v:
Liver Int
Background and aims The long-term impact of hepatitis C virus (HCV) therapy with all-oral direct-acting antivirals (DAAs) on patient-reported outcomes (PROs) has not been well-described. We characterized changes in PROs from pre-treatment to 12 month
Autor:
Jan Busby-Whitehead, Charles B Cairns, Frances S Shofer, Brenda K McCall, Ezequiel Zamora, Cory Forbach, Kevin J Biese, Timothy F Platts-Mills, Paul W Stewart, Michael A LaMantia, John S Kizer
Publikováno v:
Western Journal of Emergency Medicine, Vol 14, Iss 5, Pp 453-460 (2013)
Introduction: Triage of patients is critical to patient safety, yet no clear information exists as to the utility of initial vital signs in identifying critically ill older emergency department (ED) patients. The objective of this study is to evaluat
Externí odkaz:
https://doaj.org/article/effe7f7b10d4497c93b5d3b6de958d82
Autor:
Seth A, Berkowitz, Gina R, Kruse, Katharine A, Ball Ricks, Jessica, Burch, Ethan, Ouimet, Beth, Kitzis, Colleen, Forrest, Jean, Terranova, Paul W, Stewart, John B, Buse, Thomas C, Keyserling, Deborah J, Wexler, Linda M, Delahanty
Publikováno v:
Contemporary Clinical Trials. 124:107039
Food insecurity is associated with worse glycemic management for individuals with type 2 diabetes mellitus (T2DM), but whether medically tailored meals (MTM), a food insecurity intervention, can improve glycemic management is unclear.To describe the
Autor:
Patrick Horne, Anquenette P Sloan, K. Rajender Reddy, Mandana Khalili, Donna M. Evon, Juhi S Moon, Mark S. Sulkowski, Larry Michael, Scott Kixmiller, Michael W. Fried, David R. Nelson, Mitchell L. Shiffman, Meichen Dong, Monika Vainorius, Jama M. Darling, Jodi B Segal, Dawn Fishbein, Joy Peter, Paul W. Stewart, Summer Wadsworth, Kenneth E. Sherman, Brian L. Pearlman, Andrew J. Muir, Giuseppe Morelli, Federico Hinestrosa, Adrian M. Di Bisceglie, Prioritize Study Team, Anna S. Lok
Publikováno v:
Hepatology (Baltimore, Md.). 74(6)
Background and aims Multiple direct-acting antiviral (DAA) regimens are available to treat HCV genotype 1 infection. However, comparative effectiveness from randomized controlled trials of DAA regimens is unavailable. Approach and results We conducte
Autor:
Jipcy Amador, Anna S. Lok, Michael W. Fried, Nancy Reau, Carol E. Golin, Paul W. Stewart, Souvik Sarkar, Richard K. Sterling, Adrian M. Di Bisceglie, Marina Serper, K. Rajender Reddy, Bryce B. Reeve, David R. Nelson, Joseph K. Lim, Donna M. Evon
Publikováno v:
J Gen Intern Med
BACKGROUND: The prevalence and risk factors for non-adherence to direct-acting antivirals (DAAs) for chronic hepatitis C virus (HCV) in clinical practice settings are under-studied. OBJECTIVES: (1) To quantify DAA non-adherence in the total cohort an